Skip to Main Content

Paper Details

A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation.
Mol Diagn Ther
1
2023
Author NameAffiliation
Jean-Claude TardifUniversity of Montreal
Jean-Claude TardifMontreal Heart Institute
  • 1 - 2

Datasets

Release 1.2